CLGN
CLGN
NASDAQ · Biotechnology

Collplant Biotechnologies Lt

$0.52
-0.07 (-12.54%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 6 75%
Hold 2 25%
Sell 0 0%
Price Target
Analyst Price Target +3,231.4% upside
Low Target $14.35
Average Target $17.19
High Target $29.92
Current Price $0.52
Current
$0.52
Target
$17.19
$14.35 $17.19 avg $29.92
Scenario Analysis
Bear Case
$14.35
2,681.0%
Low target
Base Case
$17.19
+3,231.4%
Avg target
Bull Case
$29.92
+5,698.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$4.98
-89.6% from high
52-Week Low
$0.50
+4.2% from low
Target vs 52W High
$17.19
+245.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%